×
  • 業(ye) 務谘詢

    中國:

    Email: marketing@boboandtiantian.com

    業(ye) 務谘詢專(zhuan) 線:400-780-8018

    (僅(jin) 限服務谘詢,其他事宜請撥打川沙總部電話)

    川沙總部電話: +86 (21) 5859-1500

    海外:

    +1(781)535-1428(U.S.)

    0044 7790 816 954 (Europe)

    Email:marketing@medicilon.com

在線留言×
點擊切換
News information
新聞資訊

【一期一會】必威betway网址11月直播,沙龍,行業展會大放送,期待與你全球相會

2024-11-01
|
訪問量:

Tips

十一月必威betway网址將主辦2 場線上直播,同時參與(yu) 5 場海內(nei) 外行業(ye) 會(hui) 議,期待與(yu) 各位業(ye) 內(nei) 同仁交流分享藥物研發新趨勢。

必威betway网址線上直播預告
11月13日 19:00-20:00,藥效部項目經理袁雲雲博士分享,自免藥物研發利器:動物模型的構建和應用(>>預約觀看
11月27日 19:00-20:00,即將揭曉
必威betway网址線下參會預告
01  
2024/11/4-7,San Diego

15th World ADC San Diego 2024

15th World ADC San Diego 2024.webp

Antibody-drug conjugates are an important class of therapeutics for the treatment of cancer. ADCs are coming of age with a remarkable surge in recent times, that has marked a turning point in their development. 15th World ADC San Diego 2024 is only one week to go!

We are excited to invite you to visit us at Medicilon Booth #512. Our Science and Business teams are looking forward to meeting you.

02
2024/11/5-10,Houston, TX

SITC 2024

SITC 2024.webp

Ready to Meet Medicilon at SITC's 39th Annual Meeting & Pre-Conference Programs (SITC2024)? 

We are happy to meet you in person to discuss how our services and capabilities can support your research and expedite your drug discovery and development activities. Cellular immunotherapy has developed by leaps and bounds in recent years, providing a cure for many difficult-to-treat cancers. Medicilon has built a one-stop service platform for the preclinical R&D of cellular immunotherapies, covering a variety of immunotherapy methods including CAR-T, TCR-T and CAR-NK. Using a wealth of animal models and a variety of advanced analysis techniques, comprehensively considering the characteristics of different research projects, Medicilon has completed numerous pre-clinical projects for clients worldwide.

03
2024/11/9-10,成都

首屆創新藥研發和多維度治療前沿峰會

首屆創新藥研發和多維度治療前沿峰會(hui) .webp

2024年11月9-10日,由四川大學華西醫院、中國細胞生物學學會(hui) 主辦,中國免疫學會(hui) 、四川大學華西醫院生物治療全國重點實驗室、四川省國際醫學交流促進會(hui) 、四川大學華西醫院免疫炎症研究院聯合主辦,蘇州盛傑、GenEros Bio Pharma、健橋海承辦的“首屆創新藥研發和多維度治療前沿峰會(hui) 暨JAK-STAT信號通路發現30周年慶典”將在成都舉(ju) 辦。

必威betway网址創始人&CEO陳春麟博士將分享“Efficacy and Preclinical Research on JAK3 Inhibitor JANEX-1 for Treatment of Allergic Reaction and Asthma”!

必威betway网址團隊將在1號展位全程設展!

04
2024/11/13-14,廣州

第十七屆百世化學製藥國際大會暨展覽會

第十七屆百世化學製藥國際大會(hui) 暨展覽會(hui) .webp

2024年11月13-14日,由百世傳(chuan) 媒主辦,廣東(dong) 醫穀、廣東(dong) 省藥學會(hui) 製藥工程專(zhuan) 業(ye) 委員會(hui) 、廣東(dong) 省生物醫藥創新技術協會(hui) 、全球健康藥物研發中心、聊城大學生物製藥研究院等聯合主辦的“CIS-Asia 2024 第十七屆百世化學製藥國際大會(hui) 暨展覽會(hui) ”將在廣州舉(ju) 辦。

必威betway网址化學部研發副總裁李誌剛博士將分享“以靶向EGFR的PROTAC藥物研發為(wei) 例的X-TAC研發思考”!

必威betway网址團隊將在25號展位全程設展!

05
2024/11/17-20, Austin, Texas

ACT 2024

ACT 2024.webp

American College of Toxicology (ACT) 2024 kicks off on November 17 2024 at JW Marriott Austin, Austin, Texas. Maybe we can work together and Medicilon can be a great partner! Come and chat with our American team at booth #117! Medicilon offers comprehensive toxicology study services designed to assess the safety profile and potential risks of pharmaceutical compounds. Our expert team collaborates closely with clients to tailor studies according to regulatory requirements and project-specific needs. Our state-of-the-art facilities, advanced platform, experienced scientists, and commitment to quality ensure that clients receive high quality, reliable, and regulatory-compliant GLP toxicology data to support the development of safe and effective pharmaceutical products. Medicilon has been at the forefront of pharmaceutical R&D for over 20 years. We have supported more than 2,000 global clients and have contributed to the IND approval of more than 490 drugs.

聯係我們(men) .webp

marketing@boboandtiantian.com
媒體(ti) 與(yu) 會(hui) 務請聯係
必威betway网址市場部微信或郵箱

相關新聞
×
搜索驗證
點擊切換